[Cloning and sequencing of KIR2DL1 framework gene cDNA and identification of a novel allele]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Oct;33(5):694-7. doi: 10.3760/cma.j.issn.1003-9406.2016.05.026.
[Article in Chinese]

Abstract

Objective: To develop an assay for cDNA cloning and haplotype sequencing of KIR2DL1 framework gene and determine the genotype of an ethnic Han from southern China.

Methods: Total RNA was isolated from peripheral blood sample, and complementary DNA (cDNA) transcript was synthesized by RT-PCR. The entire coding sequence of the KIR2DL1 framework gene was amplified with a pair of KIR2DL1-specific PCR primers. The PCR products with a length of approximately 1.2 kb were then subjected to cloning and haplotype sequencing.

Results: A specific target fragment of the KIR2DL1 framework gene was obtained. Following allele separation, a wild-type KIR2DL1*00302 allele and a novel variant allele, KIR2DL1*031, were identified. Sequence alignment with KIR2DL1 alleles from the IPD-KIR Database showed that the novel allele KIR2DL1*031 has differed from the closest allele KIR2DL1*00302 by a non-synonymous mutation at CDS nt 188A>G (codon 42 GAG>GGG) in exon 4, which has caused an amino acid change Glu42Gly. The sequence of the novel allele KIR2DL1*031 was submitted to GenBank under the accession number KP025960 and to the IPD-KIR Database under the submission number IWS40001982. A name KIR2DL1*031 has been officially assigned by the World Health Organization (WHO) Nomenclature Committee.

Conclusion: An assay for cDNA cloning and haplotype sequencing of KIR2DL1 has been established, which has a broad applications in KIR studies at allelic level.

MeSH terms

  • Alleles
  • Base Sequence
  • China
  • Cloning, Molecular
  • DNA, Complementary / chemistry
  • DNA, Complementary / genetics*
  • Haplotypes
  • Humans
  • Male
  • Mutation, Missense*
  • Receptors, KIR2DL1 / genetics*
  • Sequence Analysis, DNA / methods*

Substances

  • DNA, Complementary
  • KIR2DL1 protein, human
  • Receptors, KIR2DL1